Dr. Rita Nanda, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Expert in Breast Cancer
Studies Breast cancer
24 reported clinical trials
47 drugs studied
About Rita Nanda, MD
Education:
- Received MD from the University of Chicago Pritzker School of Medicine.
Experience:
- Has been practicing since 2005.
- Principal investigator for the Translational Breast Cancer Research Consortium (TBCRC) and the I-SPY 2 trial.
- Leads the University of Chicago Medicine's breast cancer clinical trial program.
- Research focuses on new treatments for advanced breast cancer, with funding from notable organizations.
- Board-certified in Medical Oncology.
Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Breast Cancer
Stage III
Stage IV
HER2 negative
Affiliated Hospitals
Clinical Trials Rita Nanda, MD is currently running
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: * Sacituzumab govitecan (Trodelvy™;IMMU-132) * Pembrolizumab (Keytruda®; MK-3475)
Recruiting1 award Phase 215 criteria
Enzalutamide + Mifepristone or Chemotherapy
for Breast Cancer
The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor-positive (AR+) triple negative breast cancer (TNBC) or estrogen receptor-low breast cancer (ER-low BC), and whether these study treatments work as well as standard chemotherapy with carboplatin, paclitaxel, capecitabine, or eribulin.
Recruiting1 award Phase 218 criteria
More about Rita Nanda, MD
Clinical Trial Related8 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Rita Nanda, MD has experience with
- Pembrolizumab
- Trastuzumab
- Mifepristone
- Atezolizumab
- Sacituzumab Govitecan
- Olaparib
Breakdown of trials Rita Nanda, MD has run
Breast Cancer
Breast cancer
Parotid Gland Cancer
Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Rita Nanda, MD specialize in?
Is Rita Nanda, MD currently recruiting for clinical trials?
Are there any treatments that Rita Nanda, MD has studied deeply?
What is the best way to schedule an appointment with Rita Nanda, MD?
What is the office address of Rita Nanda, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.